TY - JOUR
KW - Clostridioides difficile
KW - England
KW - Recur
KW - healthcare costs
KW - Mortality
KW - recurrence
AU - S. Ghosh
AU - A. Antunes
AU - H. Rinta-Kokko
AU - E. Chaparova
AU - S. Lay-Flurrie
AU - A. Tricotel
AU - F. Andersson
AD - College of Medicine and Health, University College Cork, Ireland; University of Birmingham, UK.
IQVIA, Global Database Studies, Real World Solutions, Lisbon, Portugal. Electronic address: ana.antunes@iqvia.com.
IQVIA, Global Database Studies, Real World Solutions, Espoo, Finland.
IQVIA Real World Solutions, Sofia, Bulgaria.
IQVIA, Real World Solutions, London, United Kingdom.
IQVIA Real World Solutions, Paris, France.
Ferring Pharmaceuticals, Copenhagen, Denmark.
AN - 38368927
BT - Int J Infect Dis
DO - 10.1016/j.ijid.2024.02.010
DP - NLM
ET - 2024/02/19
LA - eng
N1 - 1878-3511
Ghosh, Subrata
Antunes, Ana
Rinta-Kokko, Hanna
Chaparova, Elena
Lay-Flurrie, Sarah
Tricotel, Aurore
Andersson, Fredrik L
Journal Article
Canada
Int J Infect Dis. 2024 Feb 16:S1201-9712(24)00037-7. doi: 10.1016/j.ijid.2024.02.010.
PY - 2024
SN - 1201-9712
T2 - Int J Infect Dis
TI - Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study
ER -